戻る
Ucb SA (UCBJY)価格
UCBJY 株価推移チャート
UCBJY 収入
Ucb SA
$153.7
2.33%
$3.5
終値： Jan 16, 16:00:00 GMT-5
$153.7
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$150.19
始値
$154.91
当日レンジ
$152.49 - $154.91
52週レンジ
$71.15 - $154.77
取引高
5.1K
平均取引高
27.4K
1株当たり利益(TTM)
4.02
配当利回り
--
時価総額
$58.4B
UCBJYとは何ですか？
UCB SA engages in the research and development of biopharmaceuticals products. The company is headquartered in Anderlecht, Bruxelles-Capitale and currently employs 9,378 full-time employees. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.